Some patients with myelodysplastic syndrome have an increased level of hemoglobin F in the blood.
Some patients have elevated hemoglobin F levels before therapy, while decitabine can induced hemoglobin F in others.
Factors associated with better prognosis:
(1) hemoglobin F concentration > 5%
(2) hemoglobin F prior to treatment.
(3) lower risk prognostic scoring system
To read more or access our algorithms and calculators, please log in or register.
Specialty: Hematology Oncology
